Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

New psychedelic research sheds light on why psilocybin-containing mushrooms have been consumed for centuries

by Eric W. Dolan
July 15, 2020
in Psychedelic Drugs
(Image by Michael M from Pixabay)

(Image by Michael M from Pixabay)

Share on TwitterShare on Facebook
Follow PsyPost on Google News

A new study from the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine provides insight into the psychoactive effects that distinguish psilocybin from other hallucinogenic substances. The findings suggest that feelings of spiritual and/or psychological insight play an important role in the drug’s popularity.

The new study has been published in the journal Psychopharmacology.

“Recently there has been a renewal of interest in research with psychedelic drugs,” explained Roland R. Griffiths, a professor of psychiatry and behavioral sciences who is the corresponding author of the new study.

“Studies from the Johns Hopkins Center for Psychedelic and Consciousness Research and elsewhere suggest that psilocybin, a classic psychedelic drug, has significant potential for treating various psychiatric conditions such as depression and drug dependence disorders. This study sought to address a simple but somewhat perplexing question: Why do people use psilocybin?”

“Psilocybin, in the form of hallucinogenic mushrooms, has been used for centuries for the psychoactive effects. Recent US survey studies show that lifetime psilocybin use is relatively modest and quite stable over a period of decades,” Griffiths explained.

“However, the National Institute on Drug Abuse does not consider psilocybin to be addictive because it does not cause uncontrollable drug seeking behavior, does not produce classic euphoria, does not produce a withdrawal syndrome, and does not activate brain mechanisms associated with classic drugs of abuse.”

In the double-blind study, 20 healthy participants with histories of hallucinogen use received doses of psilocybin, dextromethorphan (DXM), and a placebo during five experiment sessions.

“Dextromethorphan was chosen as a comparator to psilocybin because, although it is a hallucinogen with some effects similar to psilocybin, it has a substantially lower rate of non-medical use despite its widespread availability as an over-the-counter cough medicine,” Griffiths told PsyPost.

Each experimental session was separated by about two to seven days. The sessions took place in a living room–like environment, and the participants were instructed to lie down on a couch and listen to music.

The participants completed various assessments during the experimental sessions and wrote a brief description of their experiences afterward. In addition, the participants completed a follow-up questionnaire one week and one month after their last session.

The researchers found that most of the participants reported wanting to take psilocybin again. But only 1 in 4 reported wanting to take DXM again.

“The study showed that several subjective features of the drug experience predicted participants’ desire to take psilocybin again: psychological insight, meaningfulness of the experience, increased awareness of beauty, positive social effects (e.g. empathy), positive mood (e.g. inner peace), amazement, and mystical-type effects,” Griffiths explained.

Nearly half of the participants rated their experience following the highest psilocybin dose to be among the top most meaningful and psychologically insightful of their lives.

“The study provides an answer to the puzzle for why psilocybin has been used by people for hundreds of years, yet it does not share any of the features used to define classic drugs of abuse. The answer seems to reside in the ability of psilocybin to produce unique changes in the human conscious experience that give rise to meaning, insight, the experience of beauty and mystical-type effects,” Griffiths said.

“Future research should determine whether there are other subjective domains of subjective experience or other effects of psilocybin that motivate people to use psilocybin.”

The study, “Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan“, was authored by Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths.

(Image by Michael M from Pixabay)

TweetSendScanShareSendPin13ShareShareShare

RELATED

Promising results found as scientists probe a major hurdle in psychedelic therapy research
Psilocybin

Promising results found as scientists probe a major hurdle in psychedelic therapy research

March 18, 2024

A pivotal study explored how patient expectations affect psilocybin therapy outcomes, discovering no significant impact. Interestingly, suggestible individuals showed enhanced benefits, suggesting a unique interplay between mindset and psychedelic therapy effectiveness.

Read more
Psychedelic mushroom extract may offer enhanced brain benefits over synthetic psilocybin
Psilocybin

Psychedelic mushroom extract may offer enhanced brain benefits over synthetic psilocybin

March 17, 2024

A new study provides evidence that mushroom extract containing psilocybin may offer superior therapeutic effects for psychiatric disorders compared to synthetic psilocybin, suggesting an "entourage effect" of additional compounds enhancing treatment outcomes.

Read more
Psilocybin therapy alters prefrontal and limbic brain circuitry in alcohol use disorder
Addiction

Psilocybin therapy alters prefrontal and limbic brain circuitry in alcohol use disorder

March 16, 2024

Psilocybin therapy alters brain activity in patients with alcohol use disorder, according to new research, increasing activity in areas associated with emotional regulation and reducing activity in regions linked to craving.

Read more
Psychological experiences underlie psilocybin therapy’s success: Mystical experiences and ego dissolution identified as key mediators
Psilocybin

Psychological experiences underlie psilocybin therapy’s success: Mystical experiences and ego dissolution identified as key mediators

March 14, 2024

A groundbreaking study sheds light on psilocybin therapy's success in treating depression, highlighting the crucial roles of mystical experiences and ego dissolution, enhanced by music, in surpassing traditional treatments. The findings were published in the International Journal of Mental Health and Addiction.

Read more
New research sheds light on psychedelics’ complex relationship to psychosis and mania
Psychedelic Drugs

New research sheds light on psychedelics’ complex relationship to psychosis and mania

March 13, 2024

A JAMA Psychiatry study explores the link between psychedelic use in adolescents and mental health, finding an association with fewer psychotic symptoms and a correlation with increased manic symptoms in those with genetic risks for schizophrenia or bipolar disorder.

Read more
Ayahuasca accelerates fear extinction via its effect on serotonin receptors
Ayahuasca

Ayahuasca accelerates fear extinction via its effect on serotonin receptors

March 8, 2024

Ayahuasca was found to speed up the extinction of fear memories in rats by affecting serotonin receptors in the brain. This effect, consistent across new and old memories, points to potential therapeutic uses for anxiety and trauma-related conditions.

Read more

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

RECENT

Mental flexibility can preserve relationship satisfaction amid partner’s sleep issues

Maltreated children tend to have lower brain volumes

Mask appeal: How COVID-19 safety measures shaped online dating preferences

Groundbreaking brain implant decodes thoughts into text for paralyzed patients

Astronauts surprisingly good at judging distances without gravity

Experiments show political affiliation trumps fair play in moral evaluations

Stipends for doctoral students of psychology have not kept pace with cost of living in the U.S., study finds

Kids in ethnically diverse classrooms exhibit superior theory of mind abilities

  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy